Introduction The aims of this study were to determine the incidence of severe and moderate primary graft dysfunction (PGD) in our center, to identify, retrospectively, donors’ and recipients’ risk factors for PGD development, and to evaluate the impact of PGD within 30 days after heart transplantation. Methods Donors’ and recipients’ medical records of 64 consecutive adult cardiac transplantations performed between January 2016 and June 2017 were reviewed. The International Society for Heart and Lung Transplantation (ISHLT) criteria were used to diagnose moderate and severe PGD. Associations of risk factors for combined moderate/severe PGD were assessed with appropriate statistical analyses. Results Sixty-four patients underwent heart transplantation in this period. Twelve recipients (18.7%) developed severe or moderate PGD. Development of PGD was associated with previous donor cardiopulmonary resuscitation and a history of prior heart surgery in the recipient ( P =0.01 and P =0.02, respectively). The 30-day in hospital mortality was similar in both PGD and non-PGD patients. Conclusion The use of the ISHLT criteria for PGD is important to identify potential risk factor. The development of PGD did not affect short-term survival in our study. More studies should be done to better understand the pathophysiology of PGD.
Introduction: Among all types of transplant complications, that related to airway anastomosis, such as stenosis is still uncertain¹². Starting by the difficulty in diagnosis, such as the low precision of bronchoscopy, high cost and invasive test. This article purpose a precise and non-invasive diagnostic method of bronchial stenosis after lung transplantation based on three measures got from a reconstruction of thorax computerized tomography (CT) using a software called TeraRecon. Objective: The anastomosis index (AI), ratio of the area of the bronchial cross-section at the site of the anastomosis to the arithmetic mean of the cross-sectional areas 5 mm upstream and 5 mm downstream, obtained from reconstruction of a thorax CT has direct correlation with the bronchoscopic and clinical diagnosis of bronchial stenosis. Methods: Were obtained all cases of clinical and bronchoscopic diagnosed bronchial stenosis after lung transplantation at Heart Institute of University of São Paulo, between 2003 and 2016 (n=8). Another 8 patients, without any signs of stenosis, were selected to the control group. After that, the closest CT from the diagnostic was obtained and reconstructed using the software Terarecon, which is capable to find the exact area of any point of a cylindrical structure chosen by the operator. Then, three areas were obtained: 5mm before, at the anastomosis and 5mm after. Were calculated the Anastomosis Index (AI), which is the ratio between the area of anastomosis, and the arithmetic average of the areas 5mm before and 5mm after the anastomosis. After that, the data was confronted to variation of best FEV1 from transplantation to chosen CT and the FEV1 closest to the chosen CT. Results: As expected, in patients without bronchial stenosis, the area of the bronchi cross- section decreases linearly as it moves from proximal to distal in the bronchial tree, the AI in these cases tends to 1. Whereas, when there is no decay linear, that is, there is bronchial stenosis at the anastomosis, the AI was less than 1. There was a significant difference between AI in stenosis group (n=8, M = 0.387, SD = 0.151) and control group (n=8, M = 0.850, SD = 0.091). t(16)= -7.893 p < 0.001. This findings were supported by mean reduction of FEV1 in 17.71% and median 19.81% on stenosis group and mean reduction of 5.45%, and median 5.35% on control group. Besides that, the values undergone in a t-test, which returned a t-value = 2.879 with a p-value = 0.0129. The result is significant at p < 0.05. Conclusion: The Anastomosis Index can be useful in diagnosis of bronchial stenosis after lung transplantation, it is harmless and subsequently may help as a basis for new studies involving treatments. It is worth mentioning that is also a rational use of resources, since lower costs are generated by the CT analysis than performing a bronchoscopy, besides not requiring hospitalization and sedation, taking into account that these patients presents greater risks by the immunosuppression and other comorbidities.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.